Cyclophosphamide 50mg Injection Vials
Cyclophosphamide is an immunosuppressive and antineoplastic agent used in chemotherapy for cancers and autoimmune diseases, supplied in sterile 50mg vials for measured dosing. It fits HTS 3004.90.92.16 as a put-up unmixed product for therapeutic retail sale or hospital use.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If bulk active pharmaceutical ingredient without sterile filling or dosing
Unmixed chemical intermediates in bulk are classified under Chapter 29, not as finished medicaments.
If put up in transdermal patch form
Transdermal systems have a specific subheading within 3004 for alternative delivery methods.
If for chemical preparations not specifically for therapeutic use
If lacking clear medicinal claims or dosing, it may shift to general chemical mixtures.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Include cold chain validation documents as these are temperature-sensitive biologics
• Provide USP or EP certificates to confirm sterility and potency for CBP inspection
Related Products under HTS 3004.90.92.16
Tacrolimus 1mg Capsules
Tacrolimus capsules are immunosuppressive medicaments used to prevent organ transplant rejection, containing 1mg of the active ingredient in hard gelatin capsules for oral measured doses. Classified under HTS 3004.90.92.16 for retail-packed immunosuppressive products.
Mycophenolate Mofetil 500mg Tablets
Mycophenolate mofetil is an immunosuppressive prodrug inhibiting lymphocyte proliferation, used post-transplant in 500mg enteric-coated tablets. Under HTS 3004.90.92.16 for retail-packaged measured medicaments.
Pembrolizumab 100mg/4ml Solution
Pembrolizumab injection is an anti-PD-1 antineoplastic monoclonal antibody for various cancers, in 100mg/4ml vials for IV infusion. HTS 3004.90.92.16 applies to these dosed immunosuppressive therapies.
Imatinib Mesylate 400mg Tablets
Imatinib mesylate tablets are an antineoplastic medicament used primarily for treating chronic myeloid leukemia by inhibiting tyrosine kinase activity. They are put up in measured doses of 400mg per tablet in retail packaging, qualifying under HTS 3004.90.92.16 as an unmixed antineoplastic product for therapeutic use.
Rituximab 100mg/10ml Intravenous Infusion
Rituximab is a monoclonal antibody antineoplastic used for non-Hodgkin lymphoma and rheumatoid arthritis, provided in 100mg/10ml single-use vials for measured IV administration. It qualifies under HTS 3004.90.92.16 as an immunosuppressive biologic in dosed form.
Methotrexate 2.5mg Tablets
Methotrexate tablets are antineoplastic and immunosuppressive drugs used for cancer, psoriasis, and rheumatoid arthritis in low-dose 2.5mg scored tablets for precise therapeutic dosing. Falls under HTS 3004.90.92.16 for measured retail medicaments.